← Leaderboards
Xinyuan Chen
Massachusetts General Hospital
$4,097,118
Attributed
$4,097,118
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $707.5K · FY2013–22$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,097,118 · 6
By mechanism
R01$2,095,198 · 1
R21$865,564 · 2
R00$739,512 · 1
K99$335,910 · 1
S10$60,934 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mei X Wu$13,491,815
- Satoshi Kashiwagi$2,337,652
- Lisa M Bebell$4,084,300
- Colleen M Hadigan$2,621,754
- Bernard Khor$4,267,406
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyImmune ResponseBaseVaccinesImmunogenicityAdjuvantPre-ClinicalSkinClinicOvalbuminDendritic CellsInfluenza Virus VaccineResponseAluminum SulfateAntigensAntigen-Presenting CellsFamily SuidaeCosmeticsAnimal ModelImmunityMouse ModelVaccine AntigenAntibody Titer MeasurementSurface
Grant awards (16)
Novel adjuvant to boost humoral and cellular immune responses against influenza$410,306
R01 · FY2022 · AI · contact PI
High-density flagellin-displayed virus-like particle for universal influenza vaccine development'$236,250
R21 · FY2022 · AI · contact PI
Leica Cryostat for shared use at URI$60,934
S10 · FY2022 · OD · contact PI
Novel adjuvant to boost humoral and cellular immune responses against influenza$410,303
R01 · FY2021 · AI · contact PI
High-density flagellin-displayed virus-like particle for universal influenza vaccine development'$196,875
R21 · FY2021 · AI · contact PI
Novel adjuvant to boost humoral and cellular immune responses against influenza$410,303
R01 · FY2020 · AI · contact PI
Novel adjuvant to boost humoral and cellular immune responses against influenza$410,303
R01 · FY2019 · AI · contact PI
Novel adjuvant to boost humoral and cellular immune responses against influenza$453,983
R01 · FY2018 · AI · contact PI
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination$245,645
R00 · FY2017 · DA · contact PI
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination$245,346
R00 · FY2016 · DA · contact PI
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination$248,521
R00 · FY2015 · DA · contact PI
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination$167,184
K99 · FY2014 · DA · contact PI
Laser-based powder vaccine delivery for improved newborn immunization$148,853
R21 · FY2014 · AI · contact PI
Laser-based powder vaccine delivery for improved newborn immunization$82,614
R21 · FY2014 · AI · contact PI
Laser-based powder vaccine delivery for improved newborn immunization$200,972
R21 · FY2013 · AI · contact PI
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination$168,726
K99 · FY2013 · DA · contact PI